Briefing: Putting marginalised voices at the centre of cervical cancer screening and prevention

Quality   |   16 June 2020 

Share






Copied


Cervical cancer is the second most commonly diagnosed cancer amongst women in Bangladesh, with 8,000+ new cases reported in 2018. In response, MSI’s programme in Bangladesh (MSB) implemented a GSK funded project to provide cervical cancer screening & preventative treatment plus HPV vaccinations in Dhaka.

Across Dhaka, nearly 1,000 women were tested for precancerous cervical lesions. Women in poor areas of Dhaka, including sex workers and women living in slums, were found to be at particularly high risk, with a third of women living in slums and half of sex workers testing positive for lesions and receiving follow up treatment, including cryotherapy. WHO guidelines state that to allow the cervix to heal, women should be abstinent for at least 4 weeks following cryotherapy, or at least use condoms, but for many women, this is not feasible. 

Through our monitoring of the programme and interviews with clients, we wanted to find out: how can we make cryotherapy treatment as safe as possible for these clients? Our findings have now been published in Women’s Health, as well as in the below evidence brief. Here’s what we found and what it means for our programmes…


Share






Copied

Related posts

News


17 July 2023   |   1 min read

MSI named high-performer in 2023 Global Health 50/50 Report

In the latest Global Health 50/50 Report, which looks at the gender-related policies and practices of 200

Opinion


25 January 2024   |   5 min read

From digital support to our blue door: Building a better client journey

The power of digital is transforming client experience and expanding access to reproductive choice. Read MSI’s new

Webinar


13 February 2024   |   1 min read

Webinar: Respectful Maternity Care

Watch MSI’s webinar exploring a new approach to Respectful Maternity Care and the impact of our new training package.